Last edition
News about Global Pharma
Bharat Biotech signs agreement with Ocugen to commercialise Covaxin in Canada
Ocugen, Inc., a biopharmaceutical company, and Bharat Biotech, a global leader in vaccine innovation, announced that they have entered into an amendment to their co-development, supply, and commercialization agreement to expand Ocugen's exclusive territory to commercialize Covaxin to now also include Canada
Global Pharma | 04/06/2021 | By Darshana | 142
Bayer launches consumer health division in India
Bayer, a global life sciences company, now announces the launch of its consumer health division in India. Globally, Bayer's Consumer Health division encompasses over 140 brands. The newly launched consumer health business in India comprises of 10 trusted consumer health brands across the categories of allergy, dermatology, nutrition and analgesics
Global Pharma | 04/06/2021 | By Darshana | 232
WHO validates Sinovac-CoronaVac Covid-19 vaccine for emergency use
WHO validated the Sinovac-CoronaVac Covid-19 vaccine for emergency use, giving countries, funders, procuring agencies and communities the assurance that it meets international standards for safety, efficacy and manufacturing. The vaccine is produced by the Beijing-based pharmaceutical company Sinovac
Global Pharma | 03/06/2021 | By Darshana | 159
Biohaven's Nurtec ODT receives US FDA approval for preventive treatment of migraine
Biohaven Pharmaceutical Holding Company Ltd, a biopharmaceutical company, announced that the US Food and Drug Administration (FDA) has approved Nurtec ODT (rimegepant 75 mg) for the preventive treatment of migraine
Global Pharma | 30/05/2021 | By Darshana | 249
The Sanofi and GSK adjuvanted recombinant Covid-19 vaccine candidate achieved strong rates of neutralizing antibody responses, in line with those measured in people who have recovered from Covid-19, in all adult age groups in a phase 2 study with 722 volunteers. A global pivotal phase 3 study is expected to start in the coming weeks
Global Pharma | 18/05/2021 | By Darshana | 129
PerkinElmer to acquire Nexcelom Bioscience for US$ 260 million
Nexcelom is a leading, global provider of automated cell counting instruments, image cytometry workstations, assays and a variety of cell reagents, consumables, and fit-for-purpose cell counting method selection and development instructions that follow ISO Cell Counting Standards and aid in the development of cell and gene and immuno-oncology therapies
Global Pharma | 14/05/2021 | By Darshana | 198
Lilly gives out licences for Covid-19 drug Baricitinib to Dr Reddy's, MSN Labs and Torrent Pharmac
Eli Lilly and Company announced that it has issued additional royalty-free, non-exclusive voluntary licenses to established Indian pharma manufacturers of generic medicines, Dr Reddy's, MSN Laboratories and Torrent Pharmaceuticals, who will be collaborating with Lilly to accelerate and expand the availability of baricitinib in India
Global Pharma | 13/05/2021 | By Darshana | 457
Biogen and Capsigen announced that they have entered into a strategic research collaboration, Capsigen's proprietary TRADE platform and associated technologies will be utilized with the aim to create and identify novel AAV capsids tailored to meet disease-specific transduction profiles.
Global Pharma | 12/05/2021 | By Hemant | 393
Dr Reddy's Lab launches Avigan for COVID-19 treatment
Dr Reddy's Laboratories Ltd announced the launch of Avigan (favipiravir) 200 mg tablets in India for the treatment of patients with mild to moderate COVID-19 disease
Global Pharma | 19/08/2020 | By Darshana | 662
Aurobindo Pharma Q1 net profit rises by 22.8% to Rs. 780.6 crore
Aurobindo Pharma registered a 22.8 per cent year-on-year rise in net profit at Rs. 780.6 crore for the first quarter ended June 2020
Global Pharma | 13/08/2020 | By Darshana | 328
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy